Sabra Healthcare REIT (NASDAQ:SBRA) CEO Sells $4,166,000.00 in Stock

Sabra Healthcare REIT, Inc. (NASDAQ:SBRA) CEO Richard Matros sold 200,000 shares of the business’s stock in a transaction on Tuesday, September 8th. The shares were sold at an average price of $20.83, for a total transaction of $4,166,000.00. Following the sale, the chief executive officer directly owned 1,657,686 shares in the company, valued at approximately $34,529,599.38. This trade represents a 10.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Sabra Healthcare REIT Price Performance

SBRA opened at $20.52 on Friday. The firm has a market capitalization of $5.24 billion, a P/E ratio of 78.93, a PEG ratio of 1.58 and a beta of 0.65. The stock has a fifty day moving average of $20.70 and a 200-day moving average of $20.21. The company has a quick ratio of 3.07, a current ratio of 3.07 and a debt-to-equity ratio of 0.95. Sabra Healthcare REIT, Inc. has a 12-month low of $17.17 and a 12-month high of $22.77.

Sabra Healthcare REIT (NASDAQ:SBRA) last issued its quarterly earnings results on Monday, August 3rd. The real estate investment trust reported ($0.10) earnings per share for the quarter, missing analysts’ consensus estimates of $0.17 by ($0.27). The business had revenue of $230.11 million for the quarter, compared to analysts’ expectations of $219.39 million. Sabra Healthcare REIT had a net margin of 7.61% and a return on equity of 2.34%. The business’s quarterly revenue was up 24.7% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.38 EPS. Equities analysts forecast that Sabra Healthcare REIT, Inc. will post 1.52 EPS for the current fiscal year.

Sabra Healthcare REIT Announces Dividend

The firm also recently announced a quarterly dividend, which was paid on Monday, August 31st. Stockholders of record on Friday, August 14th were issued a $0.30 dividend. The ex-dividend date was Friday, August 14th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 5.8%. Sabra Healthcare REIT’s dividend payout ratio is currently 461.54%.

Institutional Investors Weigh In On Sabra Healthcare REIT

Several institutional investors have recently made changes to their positions in SBRA. Core Capital Management & Research inc. acquired a new stake in Sabra Healthcare REIT in the second quarter valued at approximately $204,000. Tidal Investments LLC increased its stake in shares of Sabra Healthcare REIT by 204.1% during the 2nd quarter. Tidal Investments LLC now owns 37,958 shares of the real estate investment trust’s stock worth $741,000 after purchasing an additional 25,477 shares during the last quarter. Integrated Wealth Concepts LLC bought a new position in shares of Sabra Healthcare REIT during the 2nd quarter valued at $61,000. NewEdge Advisors LLC raised its holdings in shares of Sabra Healthcare REIT by 261.2% during the 2nd quarter. NewEdge Advisors LLC now owns 71,128 shares of the real estate investment trust’s stock valued at $1,388,000 after purchasing an additional 51,435 shares in the last quarter. Finally, Baird Financial Group Inc. lifted its stake in shares of Sabra Healthcare REIT by 7.3% in the 2nd quarter. Baird Financial Group Inc. now owns 16,632 shares of the real estate investment trust’s stock valued at $324,000 after purchasing an additional 1,134 shares during the last quarter. 99.40% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

Several research firms recently commented on SBRA. Mizuho set a $21.00 price target on shares of Sabra Healthcare REIT in a report on Monday, August 31st. Raymond James Financial upgraded shares of Sabra Healthcare REIT from an “underperform” rating to a “market perform” rating in a research note on Thursday, August 6th. UBS Group set a $25.00 target price on shares of Sabra Healthcare REIT in a research report on Wednesday, July 22nd. Robert W. Baird lifted their target price on shares of Sabra Healthcare REIT from $20.00 to $21.00 and gave the company a “neutral” rating in a research note on Monday, August 31st. Finally, Weiss Ratings cut shares of Sabra Healthcare REIT from a “buy (b)” rating to a “hold (c+)” rating in a report on Tuesday, August 4th. Seven investment analysts have rated the stock with a Buy rating and seven have assigned a Hold rating to the company. According to data from MarketBeat.com, the company currently has an average rating of “Moderate Buy” and a consensus target price of $22.23.

Sabra Healthcare REIT Company Profile

Sabra Healthcare REIT, Inc is a real estate investment trust that owns and invests in healthcare-related properties. The company primarily focuses on skilled nursing and transitional care facilities, senior housing communities, behavioral health facilities, and specialty hospitals.

Sabra generally leases its properties to healthcare operators under long-term agreements, including triple-net leases, and may provide mortgage loans or other forms of financing to healthcare providers. Its portfolio serves healthcare markets across the United States and Canada.

Founded in 2010 and headquartered in Irvine, California, Sabra became a publicly traded company in 2010.